Filing Details
- Accession Number:
- 0001562180-17-003957
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-19 21:05:29
- Reporting Period:
- 2017-12-16
- Accepted Time:
- 2017-12-19 21:05:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590157 | R Andrew Robbins | C/O Array Biopharma Inc. 3200 Walnut St Boulder CO 80301 | Coo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-16 | 13,082 | $0.00 | 49,766 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-16 | 6,094 | $10.92 | 43,672 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2017-12-18 | 200,000 | $5.14 | 243,672 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-18 | 20,366 | $4.91 | 264,038 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-18 | 89,634 | $4.91 | 353,672 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-18 | 87,500 | $4.63 | 441,172 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-18 | 282,874 | $10.72 | 158,298 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2017-12-16 | 13,082 | $0.00 | 13,082 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2017-12-16 | 55,875 | $0.00 | 55,875 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2017-12-16 | 335,250 | $0.00 | 335,250 | $10.92 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-18 | 200,000 | $0.00 | 200,000 | $5.14 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-18 | 20,366 | $0.00 | 20,366 | $4.91 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-18 | 89,634 | $0.00 | 89,634 | $4.91 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-18 | 87,500 | $0.00 | 87,500 | $4.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,249 | 2020-12-16 | No | 4 | M | Direct | |
| 55,875 | 2021-12-17 | No | 4 | A | Direct | |
| 335,250 | 2027-12-16 | No | 4 | A | Direct | |
| 0 | 2022-07-31 | No | 4 | M | Direct | |
| 0 | 2017-07-23 | 2023-03-28 | No | 4 | M | Direct |
| 0 | 2023-03-28 | No | 4 | M | Direct | |
| 87,500 | 2024-04-01 | No | 4 | M | Direct |
Footnotes
- Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on December 27, 2016 as a result of the vesting of one fourth of such RSUs.
- The option vests in four equal annual installments beginning on December 16, 2018.
- The option vested in four equal annual installments beginning on July 23, 2013.
- The option vested in four equal annual installments beginning on July 23, 2014.
- The option vested in four equal annual installments beginning on April 1, 2015.
- Includes 19,687 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs.
- Represents shares withheld to satisfy tax withholding obligations of the reporting person.
- Includes 19,687 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs.
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request.
- The RSUs vested on December 16, 2017.
- Consists of remaining unvested RSUs awarded to the reporting person for no additional cash consideration on December 16, 2016, which vest in three equal remaining installments beginning December 16, 2018, and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The grant of these RSUs were previously reported on a Table II of a form 4 filed by the reporting person.
- Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018.
Billionaire Hedge Funds
